Veterinary Diagnostic Market: $3.3B to $5.0B Growth Forecast (2023-2029) | MarketsandMarkets™
August 07, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostic Market Size, Share & Trends by Product (Instrument, Consumable), Technology (Immuno (ELISA, RIA, Lateral flow), Molecular...
Tr1X Announces FDA Clearance of IND Application for TRX103, an Allogeneic Engineered Tr1 Treg Cell Therapy for Treatment-Refractory Crohn’s Disease
August 07, 2024 08:00 ET
|
Tr1X Bio
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a biopharmaceutical company specializing in allogeneic engineered Treg and CAR-Treg cell therapies with the potential to...
ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
August 07, 2024 07:50 ET
|
ZyVersa Therapeutics
Extracellular ASC has a crucial role in aggregation and deposition of amyloid A fibrils leading to associated chronic inflammatory conditions.
Dental 3D Printing Devices Market to Reach $52.2 Billion, Globally, by 2033 at 19.4% CAGR: Allied Market Research
August 06, 2024 20:30 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Dental 3D Printing Devices Market by Equipment (3D Scanner and Printer), Technology...
ADC Therapeutics berichtet über Finanzergebnisse des zweiten Quartals 2024 und gibt aktuelle Informationen zum Geschäftsbetrieb bekannt
August 06, 2024 18:51 ET
|
ADC Therapeutics SA
ZYNLONTA® – Nettoumsatz von 17,0 Mio. USD im 2. Quartal 2024; kommerzielle Rentabilität in der ersten Hälfte des Jahres 2024 erreicht Rekrutierung für die LOTIS-7-Studie verläuft planmäßig;...
Iterum Therapeutics Announces Expiration and Results of Rights Offering
August 06, 2024 17:30 ET
|
Iterum Therapeutics PLC
DUBLIN and CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and...
Kneat Announces Record Revenue for Second Quarter 2024
August 06, 2024 17:17 ET
|
kneat.com, inc.
Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook
August 06, 2024 16:02 ET
|
Inspire Medical Systems
MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of...
Global Orthopedic Splints Market to Surge Significantly at a CAGR of ~11% by 2030, | DelveInsight
August 06, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Global Orthopedic Splints Market to Surge Significantly at a CAGR of ~11% by 2030, | DelveInsight The surge in demand for orthopedic splints is...
Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
August 06, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Obesity...